Tina-quant IgM Gen.2, Catalog Nos. 03507190190, 05220726190, 03507041190, 03507149190 Product Usage: Immunoturbidimetric assay for the quantitative in vitro determination of IgM in human serum and plasma on automated clinical chemistry analyzers analyzers.
FDA Recall Z-1147-2019 · Posted 2019-04-13
Advertisement
Recalling FirmRoche Diagnostics Corporation
Recall StatusTerminated
Product CodeDAQ
Date Initiated2018-12-17
Date Terminated2020-11-02
Product Quantity5292 analytical units
Reason for Recall
New endogenous interference claims have been established for the following assays used on the cobas c 311 analyzer and the cobas c 501, 502, 701, 702, and Modular Analytics P/D modules which may have potential medical risk. ***Update: Cobas c111 and COBAS INTEGRA 400 plus analyzers are also impacted for BILT3 and LACT2 assays***
Firm Action
On 12/17/18, the firm distributed an Urgent Medical Device Correction letter to affected consignees. Customers were notified of the interference issues.
The Limitations-interference section of the method sheets for the cobas c 311 analyzer and the
cobas c 501, 502, 701, and 702 modules are being updated with the following claims:
Bilirubin Total Gen.3 assay:
Immunoglobulins: No significant interference from immunoglobulins up to a concentration of 28 g/L
(187 mol/L) (simulated by human immunogloblulin G).
Lactate Gen.2 assay (CSF samples):
Ditaurobilirubin: No significant interference from ditaurobilirubin up to an approximate concentration of
102 mol/L (6 mg/dL).
Tina-quant IGM-2 (Sensitive application):
Hemolysis: No significant interference up to an H index of 600 (approximate hemoglobin concentration of
373 mol/L or 600 mg/dL).
Lipemia (Intralipid): No significant interference up to an L index of 600
Customers were asked to do the following:
" Be aware of the new interference claims listed in this Urgent Medical Device Correction (UMDC).
This UMDC serves as labeling until the updated method sheets are available. The method sheets for
the MODULAR ANALYTICS P/D modules will not be updated.
" Manually update the H and L indexes for the IGMP2 sensitive application on your cobas c 311
analyzer or cobas c 501, 502, 701, and 702 modules following the instructions provided in this
UMDC.
" Complete all sections of the enclosed fax form (TP-00507) and fax it to 1-xxx-xxx-xxx or email it to
[email protected].
" File this UMDC for future reference.
When the method sheets are updated, they will be available on the diagnostics.roche.com
Please contact the Roche Support Network Customer Support Center, 24 hours a day, seven days a
week at 1-800-428-2336 if you have questions.
website and on the cobas e-library.
***UPDATE: Firm sent updated communication to customers dated 5/9/2019 informing them that L and H index values
Root Cause
Device Design
Distribution Pattern
US Nationwide distribution.
Related FDA 510(k) Records
Devices referenced by this recall via K-numbers.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement